The Impact of AI on Clinical Trials and Healthcare Research
Keywords:
Artificial Intelligence, Clinical Trials, Healthcare Research, Big Data, Patient Recruitment, Data Privacy, Algorithmic Bias, Molecular ModelingAbstract
Artificial intelligence (AI) has revolutionized clinical trials and healthcare research by transforming drug discovery, patient monitoring, and trial management processes. AI technologies enable healthcare practitioners and researchers to analyze vast datasets, extract meaningful insights, and make evidence-based decisions with unprecedented accuracy. The integration of AI in clinical trials has significantly enhanced trial efficiency by reducing human errors and accelerating various phases of research. AI's applications extend beyond drug development to include efficient patient recruitment, real-time monitoring through wearable devices, early complication detection, and personalized treatment approaches. However, the implementation of AI in healthcare research faces challenges including data privacy concerns, algorithmic bias, and ethical considerations regarding decision-making autonomy. Despite these challenges, AI continues to evolve, offering promising solutions for more efficient, accurate, and accessible healthcare systems.
Downloads
References
Alugubelli, R., 2016. Exploratory study of artificial intelligence in healthcare. International Journal of Innovations in Engineering Research and Technology, 3(1), pp.1-10.
Chen, L., Wang, Y., Zhang, H., Liu, M. and Chen, X., 2023. Multi-modal artificial intelligence approaches in drug discovery and repurposing: integrating chemical, biological and clinical data for enhanced therapeutic development. Pharmaceutics, 15(8), p.2156.
Crawford, K., Whittaker, M., Elish, M.C., Barocas, S., Plasek, A. and Ferryman, K., 2016. The AI now report. The Social and Economic Implications of Artificial Intelligence Technologies in the Near-Term, 2.
Du, B., An, Y., Kang, Y., Yu, X., Zhao, M., Ma, X., Ai, Y., Xu, Y., Wang, Y., Qian, C. and Wu, D., 2013. Characteristics of critically ill patients in ICUs in mainland China. Critical Care Medicine, 41(1), pp.84-92.
Fogel, D.B., 2018. Factors associated with clinical trials that fail and opportunities for improving the likelihood of success: a review. Contemporary Clinical Trials Communications, 11, pp.156-164.
Jiang, F., Jiang, Y., Zhi, H., Dong, Y., Li, H., Ma, S., Wang, Y., Dong, Q., Shen, H. and Wang, Y., 2017. Artificial intelligence in healthcare: past, present and future. Stroke and Vascular Neurology, 2(4).
Liu, Z., Liu, Y., Xu, H., He, L., Chen, Y., Fu, L., Li, N., Lu, Y., Su, T., Sun, J. and Wang, J., 2017. Effect of electroacupuncture on urinary leakage among women with stress urinary incontinence: a randomized clinical trial. JAMA, 317(24), pp.2493-2501.
Nayak, V.S., Khan, M.S., Shukla, B.K. and Chaturvedi, P.R., 2016. Artificial intelligence in clinical research. International Journal of Clinical Trials, 3(4), pp.187-193.
Nicholls, S.J., Puri, R., Ballantyne, C.M., Jukema, J.W., Kastelein, J.J., Koenig, W., Wright, R.S., Kallend, D., Wijngaard, P., Borgman, M. and Wolski, K., 2018. Effect of infusion of high-density lipoprotein mimetic containing recombinant apolipoprotein AI Milano on coronary disease in patients with an acute coronary syndrome in the MILANO-PILOT trial: a randomized clinical trial. JAMA Cardiology, 3(9), pp.806-814.
Price, I.I. and Nicholson, W., 2017. Artificial intelligence in health care: Applications and legal issues.
Svensson, S., Menkes, D.B. and Lexchin, J., 2013. Surrogate outcomes in clinical trials: a cautionary tale. JAMA Internal Medicine, 173(8), pp.611-612.
Yu, K.H., Beam, A.L. and Kohane, I.S., 2018. Artificial intelligence in healthcare. Nature Biomedical Engineering, 2(10), pp.719-731.
Zhang, S., Li, Y., Chen, W., Kumar, A. and Singh, R., 2023. Federated learning approaches for privacy-preserving clinical trial data analysis: a comprehensive review and implementation framework. Applied Sciences, 13(12), p.7089.
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJISAE open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.